Finapark is a monoamine oxidase type B (MAO-B) inhibitor indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing "off" episodes. It is not effective as a monotherapy for Parkinson’s disease
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
The exact mechanism of action of Safinamide Mesylate in Parkinson’s disease is not fully understood. Safinamide Mesylate inhibits monoamine oxidase B (MAO-B), which prevents the breakdown of dopamine, resulting in increased dopamine levels and enhanced dopaminergic activity in the brain.
There is limited experience with Safinamide overdose. If an overdose occurs, discontinue treatment and provide supportive care, including dietary restriction of tyramine for several weeks.
Common side effects include dyskinesia, falls, nausea, and insomnia.
Store below 30°C, away from light, and out of the reach of children.lofenac Potassium 50 mg Tablet, Acme Laboratories Ltd.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.